Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma.

Nanok C, Jearanaikoon P, Proungvitaya S, Limpaiboon T.

Mol Med Rep. 2018 Mar;17(3):4145-4153. doi: 10.3892/mmr.2017.8319. Epub 2017 Dec 19.

PMID:
29359783
2.

Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations.

Kim YH, Hong EK, Kong SY, Han SS, Kim SH, Rhee JK, Hwang SK, Park SJ, Kim TM.

Oncotarget. 2016 Apr 26;7(17):23825-36. doi: 10.18632/oncotarget.8183.

3.

EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3.

Tang B, Du J, Li Y, Tang F, Wang Z, He S.

Med Oncol. 2014 Nov;31(11):271. doi: 10.1007/s12032-014-0271-6. Epub 2014 Oct 4.

PMID:
25280519
4.

Bile-based detection of extrahepatic cholangiocarcinoma with quantitative DNA methylation markers and its high sensitivity.

Shin SH, Lee K, Kim BH, Cho NY, Jang JY, Kim YT, Kim D, Jang JJ, Kang GH.

J Mol Diagn. 2012 May-Jun;14(3):256-63. doi: 10.1016/j.jmoldx.2012.01.014. Epub 2012 Mar 22.

PMID:
22446083
5.

DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma.

Dachrut S, Banthaisong S, Sripa M, Paeyao A, Ho C, Lee SA, Kosinski C, Patil MA, Zhang J, Chen X, Sripa B, Pairojkul C.

Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):575-82.

6.

CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma.

Kim BH, Cho NY, Shin SH, Kwon HJ, Jang JJ, Kang GH.

Virchows Arch. 2009 Oct;455(4):343-51. doi: 10.1007/s00428-009-0829-4. Epub 2009 Sep 10.

PMID:
19763613

Supplemental Content

Loading ...
Support Center